Centers for Medicare and Medicaid Innovation; Drug Pricing and Medicare Parts B and D; Medicaid Funding; Medicare Advantage; Medicare Hospital/Provider Reimbursement Policy; Medicare Regulatory Reform; Medicare Shared Savings Program; 340B Drug Pricing Program
Government entities lobbied:Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE
HCR — Health Issues
340B Drug Pricing Program; Alternative Payment Models; Anti-Kickback Statute Reform; Artificial Intelligence; Behavioral Health; COVID-19; Drug Pricing; Emergency Provider Relief Fund; FY 2026 Appropriations; FY 2027 Appropriations; Graduate Medical Education; Health Care Innovation; Health Sector Cybersecurity; Health Workforce; Hospital at Home; Mental Health; Post-Acute and Home Health Care Payments; Stark Law Reform/Modernization; Surprise Billing/Price Transparency; Telehealth/Digital Health; Value-Based Initiatives.
Government entities lobbied:HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.